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Hepatitis B, C, and D viruses can infect liver cells and in some individuals establish a chronic phase of infection. Presently,
relatively little information is available on the antiviral mechanisms in liver cells. Because no good in vitro model infection
systems for hepatitis viruses are available, we have used influenza A, Sendai, and vesicular stomatitis (VSV) viruses to
characterize interferon (IFN) responses and IFN-induced antiviral mechanisms in human hepatoma cell lines. HepG2 or
HuH7 cells did not show any detectable IFN-a/b production in response to influenza A or Sendai virus infections. Treatment
of cells with IFN-a resulted in upregulation of IFN-a-inducible Mx, 29,59-oligoadenylate synthetase (OAS) and HLA class I
gene expression but only with exceptionally high levels of IFN-a ($100 IU/ml). Accordingly, high pretreatment levels of IFN-a,
1000 IU/ml for influenza A and VSV and 100 IU/ml for Sendai virus, were required before any detectable antiviral activity
against these viruses was seen. IFN-g had some antiviral effect against influenza A virus but appeared to be ineffective
against VSV and Sendai virus. IFN-g upregulated HLA class I protein expression, whereas Mx or OAS expression levels were
not increased. There was a modest upregulation of HLA class I expression during Sendai virus infection, whereas influenza
A virus infection resulted, after an initial weak upregulation, in a clear decrease in HLA class I expression at late times of
infection. The results suggest that hepatoma cells may have intrinsically poor ability to produce and respond to type I IFNs,
which may contribute to their inability to efficiently resist viral infections. © 1999 Academic Press
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rINTRODUCTION
Liver is the primary target of several hepatotropic
iruses like hepatitis virus A-G. Viral infections caused by
epatitis B and D and especially by hepatitis C virus
HCV) have a great tendency to remain chronic in the
iver. Viral hepatoses cause remarkable morbidity and
iver-failure-associated mortality throughout the entire
orld. Especially, the morbidity caused by hepatitis C
nfection has been steadily increasing during recent
ears and has been estimated to comprise 2% of the
opulation (Alter, 1995). Chronic disease forms of viral
epatitis predispose the patients to chronic liver failure
nd cirrhosis and, in some individuals, also to hepato-
ellular carcinoma (Saito et al., 1990; Shimotohno, 1993).
he reason for hepatitis B and C to become chronic is
omewhat unclear, but research data suggest that viral
s well as host factors are involved. Certain viral geno-
ypes may be more pathogenic than others, but racial,
ender-specific, and genetic (e.g., HLA types) factors
lso may be important (Bruno et al., 1997; Hoofnagle and
isceglie, 1997; Davis et al., 1998; McHutchison et al.,
998). It is also possible that there are some specific
eatures in the liver that render it susceptible to hepato-
ropic viral infections and prevent it from being cleared
rom the virus by innate or specific immune mechanisms.
1 To whom correspondence and reprint requests should be ad-
aressed. E-mail: Paivi.Keskinen@ktl.fi.
042-6822/99 $30.00
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364navailability of infectious high-titer stock hepatitis virus
reparations and inefficiency of in vitro hepatocyte cul-
ure systems has hampered the research developments.
Interferon-alpha (IFN-a) has initially been the drug of
hoice for chronic hepatitis B and C infections. However,
FN-a alone is not very effective against chronic hepatitis
or infections caused by genotype 1 of hepatitis C
Poynard et al., 1996; Hoofnagle and Bisceglie, 1997).
herefore combination therapies of IFN-a with other sub-
tances, such as nucleoside analogues for hepatitis B
nd Ribavirin for HCV have shown promising results
Davis et al., 1998; McHutchison et al., 1998). IFNs are
lassified into type I (IFN-a, -b, and -v) and type II (IFN-g)
FNs. Type II IFN is produced by T and NK cells, whereas
ype I IFNs are produced by leukocytes, fibroblasts, ep-
thelial, and many other cell types. IFNs have antiviral,
ntiproliferative, and immunomodulatory effects, which
re mediated by the gene products of IFN-inducible
enes (Vilcek and Sen, 1996). The antiviral effects of IFNs
re mediated by several different proteins like Mx pro-
eins, 29,59-oligoadenylate synthetase (OAS), and RNAse
and PKR (Staeheli, 1990; Sen and Ransohoff, 1993;
ilcek and Sen, 1996). IFNs also upregulate HLA class I
nd II expression (Sen and Ransohoff, 1993; Keskinen et
l., 1997), which leads to enhanced antigen presentation
nd stimulation of acquired immunity. MxA protein me-
iates resistance to several negative-strand RNA viruses
ike influenza A, VSV, bunya-, and certain paramyxovi-
uses (Pavlovic et al., 1990; Schnorr et al., 1993; Frese et
l., 1996; Kanerva et al., 1996; Zhao et al., 1996) as well as
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365IFNs AND HEPATOMA CELLSo positive-strand Semliki Forest virus (Landis et al.,
998). OAS/RNAse L pathway is involved in resistance to
t least HIV, picorna-, reo-, and vacciniaviruses (Sen and
ansohoff, 1993; Zhou et al., 1997; Maitra and Silverman,
998) and PKR plays a role in restricting the replication of
everal different viruses by downregulating the initiation
f protein synthesis (Sen and Ransohoff, 1993). Biochem-
cal evidence show that the NS5A protein from IFN-
esistant HCV genotype 1 virus directly interacts with
KR inhibiting its functions (Gale et al., 1997, 1998). Al-
hough this suggests that PKR has a role in inhibiting
CV replication, it does not rule out the possibility that
ther antiviral proteins are involved in antiviral resis-
ance in the liver. Lack of infectious HCV strains makes
t presently impossible to directly study the contribution
f each IFN-induced protein in antiviral defense.
In the present work, we have characterized interferon
esponse and IFN-induced antiviral effects in human
epatoma cell lines using three well-established viral
nfection model systems, namely influenza A, Sendai,
nd vesicular stomatitis viruses. We demonstrate that
uman hepatoma cells are not only extremely poor IFN
roducers, but they also respond to the antiviral actions
f IFN-a and IFN-g very weakly. Poor antiviral activity in
epatoma cells correlates well with a relative weakness
f IFNs to turn on IFN-inducible genes. Our results dem-
nstrate that the interferon system in liver cells functions
oorly, which could account for the impaired ability of
iver to eradicate viral infections.
RESULTS
iral protein expression in virus-infected hepatocytes
To analyze the susceptibility of hepatoma cells to viral
nfections, we carried out a kinetic infection experiment
ith a human pathogenic strain of Influenza A/Beijing/
53/89 (H3N2) and with Sendai virus, which is apatho-
enic to humans. These viruses were chosen as model
iruses because they are well characterized and they
ave been widely used in studies related to IFN and viral
athogenesis research. Virus-infected cells were har-
ested at different time points after infection, and the
xpression of viral proteins was analyzed by flow cytom-
try and Western blotting. In flow cytometric analysis,
iral protein levels started to increase already at 4 h after
nfection with both influenza A and Sendai virus infection.
iral protein expression levels steadily increased
hroughout the whole 48 h follow-up period (Fig. 1).
ased on flow cytometric analysis practically the whole
ell population was infected, and the expression level of
iral proteins was high. In Western blots viral proteins
ecame detectable at 4–8 h in influenza A (Fig. 2A) and
t 4 h in Sendai (Fig. 2B) virus infection. As in flow
ytometric analysis, the protein levels continued to in-
rease up to 48 h, suggesting that the cells were well
usceptible to infection with both types of viruses. 2ack of IFN-a/b production in virus-infected
epatocytes
Most cells respond to virus infection by producing type
IFNs. To study IFN-a/b production in hepatocytes, we
nfected HepG2 and HuH7 cells with influenza A or
endai virus (5-10 pfu/cell, respectively) and collected
ell culture supernatants at various time points after
nfection. We could not observe any measurable (sensi-
ivity limit of the assay was 3 IU/ml) IFN-a/b production in
ither cell types, suggesting that hepatoma cells were
ither unable to produce type I IFNs or that the levels
roduced remained under the detection limit of the as-
ay. RT–PCR analysis also was carried out, but no de-
ectable IFN-b mRNA expression was found in virus-
nfected hepatoma cells (results not shown). Human pri-
ary macrophages (Ronni et al., 1997; Sareneva et al.,
998) used as control cells produced ;500 and 3000
U/ml of type I IFNs within 24 h in response to influenza
and Sendai virus infection, respectively (data not
hown).
ntiviral protein expression is enhanced by Sendai
ut not by influenza A virus in hepatoma cells
Although hepatoma cells appeared to lack any detect-
ble virus-induced type I IFN production, we wanted to
nalyze whether viral infection could anyhow turn on the
xpression of Mx and OAS genes in an IFN-independent
anner as has been described to occur in certain cell
ines (Goetschy et al., 1989; Bazzigher et al., 1992; Ronni
t al., 1995). The expression of MxA, MxB, and OAS
roteins in virus-infected cells was studied by Western
lotting. Antiviral MxA protein was not detectable in
nfluenza-A-virus-infected cells (Fig. 2A), whereas in Sen-
ai-virus-infected cells (Fig. 2B) MxA protein expression
tarted to increase within 24 h. Similar pattern and ki-
etics of expression was observed for MxB protein. All
our, 100-, 69/71-, 56-, and 40/46-kDa forms of OAS pro-
ein (Marie´ et al., 1990; Rebouillat et al., 1998) were
onstitutively expressed in HepG2 cells, and no change
n expression level was seen in influenza-A-virus-in-
ected cells (Fig. 2A). Sendai virus infection appeared to
nhance the expression of all OAS isoforms including
he appearance of the 46-kDa protein form (Fig. 2B). The
esults suggest that in liver cells Sendai virus, but not
nfluenza A, can activate the expression of several IFN-
/b-inducible genes in spite of the lack of measurable
FN-a/b production.
FN-induced antiviral state in HepG2 cells
Because IFN-a is a drug of choice for viral hepatitis we
anted to analyze the sensitivity of hepatoma cells to the
ntiviral effects of IFN-a and IFN-g. HepG2 cells were
retreated with various doses of IFN-a or/and IFN-g for
4 h followed by infection with influenza A (Figs. 3 and
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366 KESKINEN ET AL.A) or Sendai (Figs. 4 and 5B) viruses. The cells were
arvested at 20 h after infection, and viral protein expres-
ion was monitored by flow cytometry and Western blot-
ing. Based on flow cytometric analysis (Fig. 3) IFN-a-
retreatment, even with the highest dose of 1000 IU/ml,
ad practically no effect on influenza virus protein ex-
ression. A clear upregulation of MxA protein and a
eak upregulation of HLA class I expression were seen,
ndicating that IFN-a was functional in these cells. Sur-
risingly high levels ($100 IU/ml) of IFN-a was required
or this upregulation. Interestingly, IFN-g alone or in com-
ination with IFN-a showed a marginal inhibitory effect
n influenza A protein expression. In the case of Sendai
irus, IFN-a pretreatment with 100–1000 IU/ml had a
etectable inhibitory effect on Sendai virus protein ex-
ression (Fig. 4). Unlike in the case of influenza A virus,
FN-g did not seem to contribute to the antiviral activity
gainst Sendai virus. Consistent with the flow cytometric
ata, Western blot analyses showed upregulation of IFN-
FIG. 1. Kinetics of virus protein expression in influenza-A-virus- or S
nfluenza A (A) or Sendai (B) viruses at a m.o.i. of 5 and 10 pfu/cell, resp
f viral proteins were analyzed by flow cytometric analysis after stainin
ntibody and secondary FITC-labeled antibodies. Time points and sta-induced Mx and OAS protein expression only with high toses of IFN-a (Fig. 5). We also tested the effect of virus
ose on the IFN-induced antiviral activities. Even with
ow-infectious virus doses (0.05–1 pfu/cell) the antiviral
ctivities of IFN-a and IFN-g were poor and similar to the
nes described above, suggesting that HepG2 cells
how relatively poor antiviral properties.
FN-induced antiviral state in HuH7 cells
To consider the possibility that HepG2 cell line was
xceptionally insensitive to the antiviral effects of IFNs,
e used another hepatoma cell line, HuH7 cells, in
imilar antiviral experiments. HuH7 cells were pretreated
ith various doses of IFN-a and/or IFN-g for 24 h, fol-
owed by infection with influenza A (Fig. 6A) or Sendai
Fig. 6B) viruses for 20 h. The cells were collected and
estern blot analyses were carried out. Similar to
epG2 cells, MxA protein expression was detectable in
ells pretreated with $100 IU/ml doses of IFN-a. Pre-
irus-infected HepG2 cells. HepG2 hepatoma cells were infected with
y. The cells were harvested at various time points, and the expression
monoclonal anti-influenza A NP antibody and rabbit anti-Sendai virus
s indicated in the figure.endai-v
ectivel
g withreatment of IFN-a or IFN-g alone had very little or no
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367IFNs AND HEPATOMA CELLSnhibitory effect, respectively, on influenza A virus HA and
P expression. However, pretreatment of cells with both
FN-a and IFN-g showed some inhibitory effect on influ-
nza A viral protein expression (Fig. 6A). Sendai virus
eemed to be somewhat more sensitive to the antiviral
ffects of IFN-a than influenza A virus. Doses .100 IU/ml
f IFN-a alone or combined with IFN-g showed clear
ntiviral effects against Sendai virus (Fig. 6B). IFN-g
lone appeared to be ineffective against Sendai virus.
omparison of IFN-induced antiviral activity in
ifferent cell lines
Because infectious progeny viruses are not produced
rom influenza-A- and Sendai-virus-infected cells, we
sed VSV to analyze the production of infectious virus in
FN-treated cells. Hepatoma cell lines as well as two
ther control cell lines, Hep2 and A549, were pretreated
ith different doses of IFN-a or IFN-g followed by infec-
ion with VSV. Cells and cell culture supernatants were
ollected, and IFN-induced inhibition of VSV protein syn-
hesis and virus production was analyzed (Fig. 7). VSV
rotein synthesis as analyzed by Western blotting and
low cytometry (Figs. 7A and 7B) or analysis of infectious
irus production (Fig. 7B) was dramatically reduced in
ep2 and A549 control cells compared to hepatoma
epG2 and HuH7 cells. At least 100 IU/ml of IFN-a was
equired before any inhibition of virus replication was
een in HepG2 or HuH7 cells. There was also a clear
ifference in the ability of IFN-a to turn on IFN-a-induced
enes. In Hep2 (expresses only MxB protein; Mele´n et
FIG. 2. Kinetics of viral, MxA, MxB, and OAS protein expression in
nfluenza A (A) or with Sendai (B) virus (m.o.i. of 5 and 10, respectively). T
roteins were analyzed by Western blotting using virus-, Mx-, and OA
arked as described previously (Lamb and Kolakofsky, 1996; Lamb anl., 1996) and in A549 cells, 10 and 1 IU/ml of IFN-a, vespectively, was sufficient to enhance Mx protein ex-
ression, whereas $100 IU/ml of IFN-a was required for
ny detectable MxA protein expression in both hepa-
oma cell lines (Fig. 7A). To study whether the differential
FN-a-induced gene expression in different cell lines
ould be due to variable expression of IFN-a-specific
ignaling molecules, we quantitated cellular p48, STAT1
nd STAT2 levels by quantitative Western blotting. Basal
48 levels in A549 and Hep2 cells were ;3- and 10-fold
igher, respectively, compared to hepatoma HepG2 and
uH7 cells whereas STAT1 and STAT2 levels appeared
o be equal in all tested cell lines (results not shown).
egulation of hepatoma cell HLA class I expression
y interferons and virus infection
During viral infections, HLA class I antigens present
irus specific peptides to effector T cells, and therefore
hey are an important part of the defense system against
iruses. Because HLA genes are also under the control
f the interferon system (Sen and Ransohoff, 1993; Kes-
inen et al., 1997), we tested the efficacy of various
oses of IFNs to upregulate HLA class I antigen expres-
ion in liver cells. As already shown above (Figs. 3 and
), very high doses, 1000 IU/ml of IFN-a are needed to
timulate HLA class I expression. Consistent with previ-
us results (Keskinen et al., 1997), IFN-g was a better
timulant of HLA class I expression compared to IFN-a.
o basal or IFN-induced HLA class II expression was
een in hepatoma cells. To study possible virus-induced
hanges in HLA class I expression, we harvested cells at
a-A- and Sendai-virus-infected cells. HepG2 cells were infected with
s were harvested at different time points, and the expression of various
ific antibodies. Time points and stainings as indicated. Viral proteins
, 1996).influenz
he cell
S-specarious time points after influenza A or Sendai infection
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368 KESKINEN ET AL.nd analyzed HLA class expression by flow cytometry. In
nfluenza-A-infected cells, HLA class I expression was
arginally increased at 8 h after infection, but thereafter
ts expression started to decrease, being ;50% of that of
ninfected cells at the 48 h time point (Fig. 8). In Sendai-
irus-infected cells HLA class I expression was different
rom that of influenza-A-infected cells. HLA class I ex-
ression increased slowly, peaking at 24 h after infec-
ion.
DISCUSSION
In the present work, we have characterized the inter-
eron system in human hepatoma, namely HepG2 and
uH7 cell lines. These cell lines, especially HepG2, have
een widely used as the model system to study liver cell
iology. Both of these cell lines are transformed, but they
xpress certain hepatocyte markers and also produce
everal compounds typical for hepatocytes. In vitro stud-
FIG. 3. Flow cytometric analysis of the kinetics of MxA, HLA class I,
epG2 cells. HepG2 cells were pretreated with various doses of IFN-a
.5). The cells were harvested at 20 h after infection and stained with A
nalysis.es with primary human hepatocytes, which constitute a80% of the liver cell population, are difficult to carry out
ecause primary hepatocytes are fragile and they sur-
ive poorly in in vitro culture conditions. The lack of
uitable infectious hepatitis stock viruses and difficulty in
ultivating of primary hepatocytes lead us to use well-
stablished virus infection model systems and hepatoma
ell lines in our analyses.
Influenza A, Sendai and vesicular stomatitis viruses
ere found to be infectious to hepatoma cells. The ki-
etics of virus infection was similar to the ones seen in
eukocytes and epithelial cells (Ronni et al., 1995, 1997;
areneva et al., 1998) with newly synthesized viral pro-
eins starting to accumulate ;4 h after infection (Figs. 1
nd 2). Influenza A or Sendai viruses are commonly used
irus infection models in IFN research because they are
ery good inducers of type I IFNs (Cantell et al., 1981;
onni et al., 1995; Sareneva et al., 1998). Presently the
nformation concerning liver cell IFN production and IFN
us protein expression in IFN-pretreated and influenza-A-virus-infected
r IFN-g for 24 h, followed by infection with influenza A virus (m.o.i. of
ainst MxA, HLA class I, or influenza A NP, followed by flow cytometricand vir
and/o
bs agction has been limited. In our hands, virus-infected
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369IFNs AND HEPATOMA CELLSepatoma cells were unable to produce any detectable
ype I IFN activity into the cell culture supernatant. The
eason for this remains unknown, but it may well be that
ome of the crucial transcription factor systems, like
nterferon regulatory factors (IRF; Nguyen et al., 1997),
equired for type I IFN gene expression function poorly in
epatocytes. In fact, we observed that in both analyzed
uman hepatoma cell lines, the constitutive expression
f IRF-1 (Mele´n et al., submitted) and IRF-7 genes (data
ot shown) were missing. IRF-1 and IRF-7 have been
uggested to be important, but perhaps not incompen-
able, transcription factors regulating the gene expres-
ion of type I IFN genes (Nguyen et al., 1997; Au et al.,
998; Marie´ et al., 1998). In addition to enhancing type I
FN gene expression, certain viruses may also directly
pregulate the gene expression of IFN-induced genes
Bazzigher et al., 1992; Goetschy et al., 1989; Ronni et al.,
995). We observed that during influenza A virus infec-
ion, MxA, MxB, OAS, or HLA class I expression were not
nhanced, suggesting that in hepatoma cells, influenza A
FIG. 4. Flow cytometric analysis of the kinetics of MxA, HLA class I,
ells. HepG2 cells first were treated 24 h with various doses of IFN-a an
arvested at 20 h after infection and stained with Abs against MxA, Hirus cannot activate transcriptional systems required for aFN-induced gene expression. Sendai virus, instead, was
ble to upregulate the expression of all of these genes;
his is consistent with the observation that certain
aramyxoviruses can efficiently activate transcriptional
ystems required for IFN and IFN-induced gene expres-
ion (Bazzigher et al., 1992; Au et al., 1998; Marie´ et al.,
998). These results suggest that influenza A and Sendai
iruses behaved quite differently in hepatoma cells. Sen-
ai virus, in spite of the lack of detectable IFN produc-
ion, was able to turn on the expression of IFN-inducible
enes, whereas influenza A virus is incapable of doing it.
hether hepatotropic viruses can activate IFN produc-
ion or IFN-inducible gene expression in liver cells will be
f great interest to study. It may be that hepatitis B and C
re poor IFN inducers because HBV- or HCV-infected
ndividuals showed no expression of MxA protein in their
eukocytes, which provide indirect evidence of the lack of
ype I IFN production (Jakschies et al., 1994).
Type I IFN-inducible genes Mx, OAS/RNAse L, PKR,
nd some other less well-studied molecules mediate
rus protein expression in IFN-pretreated Sendai-virus-infected HepG2
N-g, followed by infection with Sendai virus (m.o.i. of 1). The cells were
s I, or virus protein followed by flow cytometric analysis.and vi
d/or IFntiviral actions against different viruses (Staeheli, 1990;
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370 KESKINEN ET AL.en and Ransohoff, 1993). Stimulation of hepatoma cells
ith IFNs followed by virus challenge showed relatively
oor antiviral activity against both influenza A and Sendai
iruses. In HepG2 cells, IFN-a pretreatment had practi-
ally no effect on influenza A virus protein expression.
FN-g alone or in combination with IFN-a showed some
FIG. 5. Kinetics of MxA, MxB, OAS, and viral protein expression in
FN-pretreated virus-infected HepG2 cells. HepG2 cells were pre-
reated with various doses of IFN-a and/or IFN-g for 24 h, followed by
nfection with influenza A (A) or Sendai (B) viruses (m.o.i. of 0.5 and 1,
espectively). The cells were harvested at 20 h after infection. Western
lots were stained with Abs against MxA, MxB, OAS, and virus protein.ntiviral activity. The results suggest that hepatoma cells ihow relatively poor IFN-a-induced antiviral action
gainst influenza A infection. This is surprising because
FN-a turned on the expression of MxA protein, which
as previously been shown to mediate resistance to
nfluenza A virus in vitro (Pavlovic et al., 1990; Ronni et al.,
995). It is possible that IFN-a-induced expression of
xA protein is not sufficiently high in liver cells to me-
iate influenza A virus resistance. Alternatively, liver cells
re lacking some other factors or antiviral proteins,
hich contribute to the antiviral actions against influenza
virus. In Sendai infection, IFN-a-pretreatment at doses
f 100–1000 IU/ml showed a dose-dependent inhibition
n viral protein expression. Unlike in the case of influenza
, IFN-g alone had no effect on Sendai virus protein
xpression. The inefficiency of hepatoma cells to resist
irus infection appeared to be independent of virus dose,
ecause even the smallest doses of influenza A (0.02
fu/cell) or Sendai (0.04 pfu/cell) viruses showed require-
ent of high IFN-a doses for any antiviral activity to be
een. Similarly, in the case of VSV, both viral protein
ynthesis and infectious virus production were poorly
nhibited by IFNs in hepatoma cells. This impaired IFN-
nduced antiviral activity was not restricted to HepG2
ells because HuH7 cells behaved practically in a similar
ashion (Fig. 6). These data match well with the clinical
bservations that HCV patients benefit from higher IFN-a
oses (Poynard et al., 1996).
In HepG2 and HuH7 cells, exceptionally high IFN-a
oses ($100 IU/ml) were needed to turn on the expres-
ion of MxA and MxB proteins even though the basal
xpression levels were undetectable. In other cell types
ike in human blood mononuclear cells, mature macro-
hages or epithelial A549 cells MxA gene expression is
urned on with IFN-a doses as low as 1 IU/ml (Fig. 7;
onni et al., 1993, 1997, 1998; Mele´n et al., 1996). In-
reased OAS protein expression (100- and 69/71-kDa
soforms only; Fig. 5) also was seen, but, as in the case
f Mx proteins, only with high IFN-a doses. It may be that
onstitutive OAS expression levels were relatively high,
nd therefore we were unable to detect any clear in-
rease in some OAS isoform expression. The reason for
he insensitivity of hepatoma cells to the antiviral actions
f IFN-a is unclear, but it may be that hepatoma cells
ave a relative reduction in p48 protein expression (Me-
e´n et al., submitted) that renders the cells weakly re-
ponsive to IFN-a.
A crucial factor in the development of virus-specific
mmune responses is the functionality of the MHC sys-
em. MHC class I and II molecules are constitutively
xpressed either in most cells or in professional antigen
resenting cells, respectively, but their expression is also
nder the regulation of the IFN system (Sen and Ranso-
off, 1993). In this manner, IFNs can enhance the pre-
entation of virus-specific peptides by MHC class I mol-
cules, thus leading to more efficient killing of virus-nfected cells by cytotoxic T cells. Hepatoma cells readily
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371IFNs AND HEPATOMA CELLSxpressed HLA class I molecules, and their expression
as increased, although in a limited fashion, by both
ypes of IFNs. This may indicate that IFN-a can only
eakly stimulate the antigen presentation capacity of
iver cells. Influenza A infection also marginally in-
reased HLA class I expression at early times of infec-
ion, but at later time points its expression was de-
reased. This may be due to initial virus-induced upregu-
ation of HLA class I expression, but as the infection
roceeds, due to a destruction of host premRNA mole-
ules by influenza A virus RNA polymerase complex. The
FIG. 6. Kinetics of viral and antiviral MxA protein expression in IFN-p
oses of IFN-a and/or IFN-g for 24 h, followed by infection with influenz
arvested at 20 h after infection. Blots were stained with Abs againstiral polymerase complex uses the so-called “cap- anatching” mechanism in the cell nucleus to cleave a
rimer for its own mRNA synthesis (Lamb and Krug,
996). This leads to the degradation of host cell
remRNAs including those of HLA mRNAs (Keskinen et
l., 1997) followed by inhibition of cellular protein synthe-
is. Sendai virus, which replicates in the cell cytoplasm,
ehaved differently, and a steady, although relatively
eak increase in HLA class I expression was seen
uring the infection.
Liver is a specialized organ build-up to synthesize a
umber of different important molecules like albumin
ed virus-infected HuH7 cells. HuH7 cells were pretreated with various
or Sendai (B) viruses (m.o.i. of 0.5 and 1, respectively). The cells were
d virus proteins.retreat
a A (A)nd acute-phase serum proteins. In addition, it is re-
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372 KESKINEN ET AL.ponsible for detoxification of potentially hazardous
ubstances in the body. Besides all these important
unctions, liver cells seemed to be rather poor, at least
ased on in vitro experiments with cultured hepatoma
ells, in coping with viral infections. They seem to lack
ny measurable type I IFN production, and they also
esponded very poorly to the antiviral activities of
FNs. The reason(s) for this impaired capacity to resist
iral infections is presently not known but may at least
artially be due to the lack of expression of transcrip-
ion factors involved in type I IFN gene expression.
nother explanation could be a relative reduction in
FN-a-specific signaling molecules such as p48.
FIG. 7. Interferon-induced antiviral activity against VSV. Larynx epider
ells were pretreated with different doses of IFN-a or IFN-g for 24 h fol
upernatants were collected at 20 h after infection. (A) Western blot an
ells only), anti-MxA, or anti-VSV antibodies as indicated in the figure. (B
nd FITC-labeled goat anti-rabbit antibodies and analyzed by flow cyto
rotein expression. (C) Production of infectious VSV. Cell culture super
laque assay in Hep2 cells. Virus yields are shown in a logarithmic scaken together, hepatoma cells seem to be weakly yesponsive to IFNs, which logically would provide one
xplanation why the liver is the target tissue for sev-
ral chronic viral infections. However, studies with
ormal human hepatocytes are urgently needed to
haracterize the IFN system in normal conditions.
MATERIALS AND METHODS
ell culture
HepG2 human hepatoma cells (ATCC HB-8065) were
aintained in Dulbecco’s modified Eagle’s medium
DMEM) supplemented with penicillin (0.6 mg/ml), strep-
omycin (60 mg/ml), glutamine (2 mM), N-2-hydroxyeth-
rcinoma Hep2, lung carcinoma A549 and hepatoma HepG2 and HuH7
y infection with VSV (1-5 pfu/cell). Virus-infected cells and cell culture
Blots (10 mg of protein/lane) were stained with rabbit anti-MxB (Hep2
cytometric analysis. Cells were stained with rabbit anti-VSV antibodies
FACScan with Cellquest software). Results are shown as relative viral
from IFN pretreated and virus-infected cells were subjected to virus
N doses as indicated in the figure.moid ca
lowed b
alysis.
) Flow
metry (
natantslpiperazine-N9-2-ethanesulfonic acid (HEPES) buffer, pH
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373IFNs AND HEPATOMA CELLS.4 (20 mM), and 10% fetal calf serum (FCS) (Integro,
aandam, Netherlands). HuH7 human hepatocellular
arcinoma (Nakabayashi et al., 1982), Hep2 human lar-
nx epidermoid carcinoma (ATCC CCL23), and A549 hu-
an lung carcinoma (ATCC CCL 185) cells were main-
ained in minimal essential medium (MEM) with supple-
ents as described above.
nterferons
Type I human leukocyte IFN-a (6 3 106 IU/ml; specific
ctivity of 2 3 108 IU/mg; Cantell et al., 1981) was kindly
rovided by Dr. Kari Cantell at the National Public Health
nstitute, Helsinki. Human IFN-g (1 3 106 IU/ml; specific
ctivity of 1.1 3 107 IU/mg) was obtained from the Finnish
ed Cross Blood Transfusion Service, Helsinki, and it
as prepared and purified as described elsewhere (Can-
ell et al., 1986). Interferons were used at concentrations
FIG. 8. Kinetics of HLA class I expression in influenza-A-virus- or
endai-virus-infected HepG2 cells. HepG2 hepatoma cells were in-
ected with influenza A (A) or Sendai (B) viruses (m.o.i. of 0.5 and 1,
espectively). The cells were harvested at various time points, fixed and
tained for HLA class I expression followed by flow cytometric analysis.
ime points and stainings as indicated.s indicated in each experiment. girus infections
The stock of human pathogenic influenza virus strain
/Beijing/353/89 (H3N2) was originally obtained from the
ational Institute for Medical Research (London). Sendai
irus stock (strain Cantell) is from the National Public
ealth Institute, Helsinki. Virus stocks were cultivated in
-day-old embryonated hen’s eggs and stored at 270°C.
he hemagglutination titers of influenza and Sendai vi-
uses were 128 and 6000, respectively, as determined by
he standard micro-method (WHO Collaborating Centers
or Reference and Research on Influenza, 1982). The
gg-infectious dose (EID50) of the influenza A virus stock
as 9.6 3 108/ml. Depending on virus infection experi-
ents, we used virus doses of 0.5-5 pfu/cell for influenza
, 1-10 pfu/cell for Sendai virus, and 1-5 pfu/cell for VSV
Indiana strain). VSV stocks were grown in Hep2 and the
tock virus had a titer of 4 3 106 pfu/ml.
etection of IFN-a/b
Culture media from virus-infected cells were treated at
H 2 and assayed for the presence of IFN-a/b activity in
ep2 cells by VSV plaque reduction assay (Cantell et al.,
991). The results are expressed as IU/ml, using an
nternational control IFN-a preparation as the laboratory
tandard. RT–PCR analysis was carried out with Clon-
ech RT–PCR kit with oligonucleotides 59 TGT TGT TGA
AT GAC CAA CAA GTG TCT C (upstream oligonucleo-
ide) and 59 GCA CAG GCT AGG AGA TCT TCA GTT TCG
(downstream oligonucleotide) specific for human
FN-b gene.
ntibodies
The following primary antibodies were used: mouse
onoclonal anti-HLA-A,B,C (used at 1:8 dilution, ATCC
B95), mouse monoclonal anti-influenza A nucleoprotein
1:500, IC9 anti-NP, kindly provided by Dr. J. Yeddel, NIH,
D), rabbit anti-NP (1:500, Ronni et al., 1995), rabbit
nti-Sendai (1:1000, Julkunen et al., 1983), rabbit anti-VSV
1:500), rabbit anti-MxA (1:1000, Ronni et al., 1993),
uinea pig anti-MxA and anti-MxB (1:600 and 1:150, re-
pectively, Mele´n et al., 1996). Rabbit anti-OAS antibod-
es (1:500) were prepared against Escherichia coli-ex-
ressed GST-OAS fusion protein. The cDNA for rat 40- to
6-kDa form of OAS was kindly provided by Dr. E. Truve
Tallinn, Estonia). The following secondary antibodies
ere used: FITC-conjugated sheep anti-rabbit IgG
(ab9)2 fragment (1:100, Boehringer Mannheim, Mann-
eim, Germany), FITC-conjugated sheep anti-mouse IgG
(ab9)2 fragment (1:100, Boehringer Mannheim), HRP-
onjugated goat anti-rabbit (1:2000, Bio-Rad Laborato-
ies, Richmond, CA), and HRP-conjugated goat anti-
uinea pig (1:1000, Dako, Glostrup, Denmark).
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374 KESKINEN ET AL.low cytometric analysis
For flow cytometric analysis, cells were detached with
rypsin at 37°C followed by washing with PBS and fixing
ith Facs lysing solution (Becton Dickinson, San Jose,
alifornia) according to manufacturer’s instructions. With
his fixation process the cells also were permeabilized,
hich enabled staining for both cell surface and intra-
ellular antigens. After fixation and washing, the cells
ere suspended in PBS containing 0.5% BSA and 2%
ormal human serum (NHS). Primary staining was car-
ied out for 30 min at 37°C. After washing with PBS,
econdary staining was carried out for 30 min at 37°C.
fter washings, the cells were suspended in PBS con-
aining 0.5% BSA and 10,000 cells were analyzed by flow
ytometry as recommended by the manufacturer (FACS-
an with Cellquest software, Becton Dickinson, Moun-
ain View, CA).
el electrophoresis and Western blotting
SDS–PAGE was carried out using the Laemmli buffer
ystem (Laemmli, 1970). Proteins separated on gels were
ransferred to Immobilon-P (polyvinylidene difluoride,
VDF) membranes (Millipore, Bedford, MA) with an Iso-
hor electrotransfer apparatur (Hoefer Scientific Instru-
ents, San Francisco, CA) at 200 mA for 1 h. The primary
nd secondary antibody binding was carried out in PBS
ontaining 5% nonfat milk for 1 h at 37°C. After primary
nd secondary staining, blots were washed three times
or 10 min. The protein bands were visualized on Amer-
ham Hyper-Max film by the ECL chemiluminescence
ystem as recommended by the manufacturer (Amer-
ham, Buckinghamshire, UK). Protein concentrations in
he samples were determined with the BioRad protein
ssay kit.
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